Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicity.
Simone MorraCristina Cano GarciaMattia Luca PiccinelliStefano TapperoFrancesco BarlettaReha-Baris IncesuLukas ScheipnerAndrea BaudoZhe TianMario de AngelisVincenzo MironeGianluigi CalifanoGiuseppe CelentanoFred SaadShahrokh F ShariatFelix K H ChunOttavio de CobelliGennaro MusiCarlo TerroneAlberto BrigantiDerya TilkiSascha AhyaiLuca CarmignaniNicola LongoPierre I KarakiewiczPublished in: International journal of urology : official journal of the Japanese Urological Association (2024)
Relative to SSA Life Tables, the highest 5-year OS disadvantage applied to stage III NS-TGCT Asian/Pacific Islander race/ethnicity group, followed by African American, Hispanic and Caucasian, in that order.
Keyphrases